# Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?

> **NCT00259168** · PHASE4 · COMPLETED · sponsor: **Atheline Major-Pedersen** · enrollment: 70 (actual)

## Conditions studied

- Insulin Resistance
- Impaired Fasting Glucose

## Interventions

- **DRUG:** Nateglinide

## Key facts

- **NCT ID:** NCT00259168
- **Lead sponsor:** Atheline Major-Pedersen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2018-12-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259168, "Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00259168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*